Blood Bcl-2 levels to predict the mortality of septic patients

Biomark Med. 2022 Apr;16(6):427-433. doi: 10.2217/bmm-2021-0226. Epub 2022 Mar 22.

Abstract

Aim: To determine whether blood concentrations of Bcl-2 during the 1st week of sepsis could help predict mortality. Methods: Serum Bcl-2 concentrations were determined at the 1st, 4th and 8th days of sepsis diagnosis. Results: Thirty-day surviving patients (n = 168) showed higher serum Bcl-2 levels at the 1st (p = 0.002), 4th (p < 0.001) and 8th days (p < 0.001) of sepsis diagnosis than non-surviving patients (n = 91). An association between serum Bcl-2 concentrations at the 1st (p = 0.003), 4th (p < 0.001) and 8th days (p = 0.01) and 30-day mortality after controlling for diabetes mellitus, Sepsis-related Organ Failure Assessment, lactic acid and age was found in the multiple logistic regression analysis. Conclusions: The novel finding is that blood Bcl-2 concentrations at any time in the 1st week of sepsis are associated with mortality.

Keywords: Bcl-2; apoptosis; mortality; outcome; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lactic Acid
  • Prognosis
  • Sepsis*
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Lactic Acid